In contrast with the low frequency of most single epitope reactive T cells in the preimmune repertoire, up to 1 of 1,000 naive CD8+ T cells from A2+ individuals specifically bind fluorescent A2/peptide multimers incorporating the A27L analogue of the immunodominant 26–35 peptide from the melanocyte differentiation and melanoma associated antigen Melan-A. This represents the only naive antigen-specific T cell repertoire accessible to direct analysis in humans up to date. To get insight into the molecular basis for the selection and maintenance of such an abundant repertoire, we analyzed the functional diversity of T cells composing this repertoire ex vivo at the clonal level. Surprisingly, we found a significant proportion of multimer+ clonotypes that failed to recognize both Melan-A analogue and parental peptides in a functional assay but efficiently recognized peptides from proteins of self- or pathogen origin selected for their potential functional cross-reactivity with Melan-A. Consistent with these data, multimers incorporating some of the most frequently recognized peptides specifically stained a proportion of naive CD8+ T cells similar to that observed with Melan-A multimers. Altogether these results indicate that the high frequency of Melan-A multimer+ T cells can be explained by the existence of largely cross-reactive subsets of naive CD8+ T cells displaying multiple specificities.
Skip Nav Destination
Article navigation
15 July 2002
Article|
July 15 2002
Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans
Valérie Dutoit,
Valérie Dutoit
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Search for other works by this author on:
Verena Rubio-Godoy,
Verena Rubio-Godoy
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Search for other works by this author on:
Mikäel J. Pittet,
Mikäel J. Pittet
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Search for other works by this author on:
Alfred Zippelius,
Alfred Zippelius
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Search for other works by this author on:
Pierre-Yves Dietrich,
Pierre-Yves Dietrich
2Division of Oncology, Laboratory of Tumor Immunology, University Hospital (HUG), Geneva 1211, Switzerland
Search for other works by this author on:
Frédérique Anne Legal,
Frédérique Anne Legal
2Division of Oncology, Laboratory of Tumor Immunology, University Hospital (HUG), Geneva 1211, Switzerland
Search for other works by this author on:
Philippe Guillaume,
Philippe Guillaume
3Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges 1066, Switzerland
Search for other works by this author on:
Pedro Romero,
Pedro Romero
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Search for other works by this author on:
Jean-Charles Cerottini,
Jean-Charles Cerottini
3Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges 1066, Switzerland
Search for other works by this author on:
Richard A. Houghten,
Richard A. Houghten
4Torrey Pines Institute for Molecular Studies and Mixture Science Inc., San Diego, CA 92121
Search for other works by this author on:
Clemencia Pinilla,
Clemencia Pinilla
4Torrey Pines Institute for Molecular Studies and Mixture Science Inc., San Diego, CA 92121
Search for other works by this author on:
Danila Valmori
Danila Valmori
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Search for other works by this author on:
Valérie Dutoit
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Verena Rubio-Godoy
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Mikäel J. Pittet
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Alfred Zippelius
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Pierre-Yves Dietrich
2Division of Oncology, Laboratory of Tumor Immunology, University Hospital (HUG), Geneva 1211, Switzerland
Frédérique Anne Legal
2Division of Oncology, Laboratory of Tumor Immunology, University Hospital (HUG), Geneva 1211, Switzerland
Philippe Guillaume
3Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges 1066, Switzerland
Pedro Romero
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Jean-Charles Cerottini
3Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges 1066, Switzerland
Richard A. Houghten
4Torrey Pines Institute for Molecular Studies and Mixture Science Inc., San Diego, CA 92121
Clemencia Pinilla
4Torrey Pines Institute for Molecular Studies and Mixture Science Inc., San Diego, CA 92121
Danila Valmori
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland
Address correspondence to Danila Valmori, Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Hôpital Orthopédique, Avenue Pierre-Decker 4, 1011 Lausanne, Switzerland. Phone: 4121-31401-78; Fax: 4121-31474-77; E-mail: [email protected]
Received:
February 13 2002
Revision Received:
June 05 2002
Accepted:
June 06 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (2): 207–216.
Article history
Received:
February 13 2002
Revision Received:
June 05 2002
Accepted:
June 06 2002
Citation
Valérie Dutoit, Verena Rubio-Godoy, Mikäel J. Pittet, Alfred Zippelius, Pierre-Yves Dietrich, Frédérique Anne Legal, Philippe Guillaume, Pedro Romero, Jean-Charles Cerottini, Richard A. Houghten, Clemencia Pinilla, Danila Valmori; Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans . J Exp Med 15 July 2002; 196 (2): 207–216. doi: https://doi.org/10.1084/jem.20020242
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement